Creative Planning trimmed its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 2.0% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,348 shares of the pharmacy operator’s stock after selling 2,445 shares during the quarter. Creative Planning’s holdings in Walgreens Boots Alliance were worth $9,346,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Russell Investments Group Ltd. increased its holdings in shares of Walgreens Boots Alliance by 72.9% during the 1st quarter. Russell Investments Group Ltd. now owns 482,962 shares of the pharmacy operator’s stock valued at $40,115,000 after purchasing an additional 203,635 shares in the last quarter. Wellington Management Group LLP increased its holdings in shares of Walgreens Boots Alliance by 5.9% during the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after purchasing an additional 1,824,300 shares in the last quarter. Putnam FL Investment Management Co. increased its holdings in shares of Walgreens Boots Alliance by 1,037.3% during the 1st quarter. Putnam FL Investment Management Co. now owns 74,860 shares of the pharmacy operator’s stock valued at $6,217,000 after purchasing an additional 68,278 shares in the last quarter. Sumitomo Mitsui Asset Management Company LTD increased its holdings in shares of Walgreens Boots Alliance by 9.3% during the 1st quarter. Sumitomo Mitsui Asset Management Company LTD now owns 75,821 shares of the pharmacy operator’s stock valued at $6,296,000 after purchasing an additional 6,462 shares in the last quarter. Finally, Welch & Forbes LLC increased its holdings in shares of Walgreens Boots Alliance by 4.8% during the 1st quarter. Welch & Forbes LLC now owns 96,882 shares of the pharmacy operator’s stock valued at $8,046,000 after purchasing an additional 4,453 shares in the last quarter. 60.16% of the stock is owned by hedge funds and other institutional investors.

Several equities research analysts recently commented on the stock. Morgan Stanley reissued an “overweight” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, August 30th. Royal Bank Of Canada assumed coverage on shares of Walgreens Boots Alliance in a report on Tuesday. They issued an “outperform” rating and a $96.00 price target for the company. Citigroup Inc. reissued a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, Loop Capital assumed coverage on shares of Walgreens Boots Alliance in a report on Thursday, August 24th. They issued a “buy” rating and a $95.00 price target for the company. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $92.06.

TRADEMARK VIOLATION WARNING: This piece was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/23/creative-planning-sells-2445-shares-of-walgreens-boots-alliance-inc-wba.html.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) traded up 0.27% on Friday, hitting $78.41. 5,001,271 shares of the stock traded hands. The firm’s 50 day moving average is $81.36 and its 200-day moving average is $81.86. The company has a market cap of $83.91 billion, a PE ratio of 19.80 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating analysts’ consensus estimates of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The business had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. During the same quarter last year, the business posted $1.18 earnings per share. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

Walgreens Boots Alliance declared that its Board of Directors has authorized a share repurchase plan on Thursday, June 29th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.04%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 40.30%.

In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is available at this link. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.